Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROCADERO: Caffeine for Ticagrelor-Related Dyspnea
NCT02311088Phase 2Terminated
- Sponsor
- Uppsala University
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caffeine in Dyspnea, sponsored by Uppsala University. Started Dec 2014; status: terminated.
02
Drugs
caffeine
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT02311088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311088.